Last month in Amsterdam, The Netherlands, on April 25-26, the eyeforpharma 5th Annual Real World Evidence Europe conference was attended with around 250 pharma industry leaders, payers, and subject matter experts. The conference agenda was comprised of current challenges, latest innovations and future trends in RWE, a subject of great interest to many key stakeholders in drug development.
The two-day event saw speakers grappling with important ideas centered around RWE including the necessity for cross-functional working within companies; patient centricity; value-based outcomes for healthcare systems; the challenges related to RWE terminology; challenges regarding reimbursement and payment models; the practical application of cross-functional working in RWE; and much more.
View a detailed report on the conference here.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.